Four different types of binding sites are available for tubulin to interact with inhibitors, which are laulimalide, taxane/epothilone, vinca alkaloid, and colchicine sites 1 . Tubulin binding agents can be classified into two types based on their mechanism of action as microtubule destabilizing (such as such as Vincristine, Vinblastine, Combretastatin-A4) and microtubule-stabilizing drugs (such as Taxanes and epothilones). The destabilizing drugs bind to one of two tubulin binding sites (vinca, colchicines site), the stabilizing drugs binds to taxane binding site 2, [5] [6] . Out of four binding domains colchicine binds with high affinity to tubulin, colchicine binds to beta-tubulin and forms entangled tubulin dimer and it prevents to adopt straight structure, which inhibits the microtubule assembly 7 . Several natural products and modified natural products interact with tubulin, which are in clinical trials 4 . Taxanes and vinca alkaloids are effective antimitotic agents, but when administrated as combination chemotherapy it shows enhanced myeloid and neurologic toxicity. Presently the combination was excluded from clinical trials 8 . Colchicine was not clinically used as cancer drug, but it has been studied as tubulin domain binder 4 . Because of this there is an urgent need to develop antitubulin inhibitors with effective biological properties. Chalcones belong to colchicine domain binding groups, and is naturally occurring compound belong to flavonoid structure. The chalcones are yellow pigments in flowers, and are found in various plant parts ((roots, rhizomes, heartwood, buds, leaves, flowers, and seeds) of species of genera Angelica, Sophora, Glycyrrhiza, Humulus, Scutellaria, Parar tocarpus, Ficus, Dorstenia, Morus, Artocarpus) [9] [10] . The chalcone compounds possess various biological activities such as anti-cancer, antioxidant, antimicrobial, antiinflammatory, analgesic, anti-ulcerative, immune modulatory, antimalarial, antiviral, anti-leishmanial, anti-tubercular, anti-hyperglycemic etc. [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] . In the present study pharmacophore model, 3D QSAR and molecular docking studies on tubulin inhibitors were developed. These studies are useful in designing new tubulin inhibitors.
MATERIALS AND METHODS

Data set
A set of 38 Chalcone compounds with tubulin inhibitory activity were collected from various previous results and the inhibitory activity of the compounds against tubulin were converted in to pIC50 are shown in Table 1 and 2 [23] [24] .
Molecular modeling
All 38 compounds were drawn using ISIS draw, further Ligprep module used in minimization of compounds using semi-empirical OPLS_2005 force field. It converts the 2D structures in to 3D structures, generates tautomers and neutralizes charged structures.
Pharmacophore studies
A common pharmacophore hypothesis is a spatial arrangement of chemical features common to two or more active ligands, which is proposed to explain the key interactions involved in ligand binding. To generate common pharmacophore hypothesis, the ligands were divided into actives and inactive by activity threshold value. The activity threshold value was 6 for active and 5 for inactive ligand. The dataset pIC50 activity distribution ranges from 4.003-6.552. The ligands were used for generating pharmacophore and QSAR modeling. PHASE module of Schrodinger software was used to generate pharmacophore model. Phase utilizes fine-grained conformational sampling and scoring techniques to identify common pharmacophore hypotheses 25 . To identify common pharmacophore hypothesis six pharmacophore features: H-bond acceptor (A), H-bond donor (D), hydrophobic group (H), negatively charged group (N), positively charged group (P) and aromatic ring (R) were selected. The hypothesis identified by Phase is scored according to how the active ligands superimpose on features associated with that hypothesis. The high scoring hypothesis used to create 3D QSAR model.
QSAR model
QSAR model is carried out using high score hypothesis by dividing the dataset as training set (80%) and test set (20%). PHASE has two types of molecular alignment, one is pharmacophore based alignment and other one is atom based alignment [25] [26] . Atom based QSAR model is more useful in explaining the structure activity relationship. Phase QSAR models are based on partial least-squares (PLS) regression. Atom based QSAR were generated for selected hypothesis using 31 training set and 7 test set using grid spacing of 1.0 Å and four components of PLS factor, the model is validated by predicted activities of test set compounds.
Docking studies
Molecular Docking studies carried out using LigandFit module in Discovery studio. The LigandFit docking procedure consists of specifying the region of the receptor to use as the binding site for docking and the Docking of the ligands in the specified binding site 27 . The crystal structure of the beta-tubulin (PDB ID: 1SA1) is downloaded from protein data bank (http://www.rcsb.org/pdb). Protein preparation was carried out by deleting water molecules, adding hydrogens to receptor and CHARMm force field applied to the receptor. After protein preparation the active sites were searched using flood filling algorithm and partition site was adjusted for the better fits of molecule in the partition site of receptor. All 38 compounds were docked in to the active site of the 1SA1. During the docking process top 10 conformations of ligands were generated based on the dock score value.
RESULTS AND DISCUSSION
In the present study ligand based pharmacophore, atom based QSAR studies on chalcone derivatives were carried out to elucidate structural features to inhibit tubulin receptor. The molecular docking studies to find binding interactions of ligand with tubulin receptor.
F o r t h e g e n e r a t i o n o f c o m m o n pharmacophore model, the data set was divided into actives (> 6) and in actives (<5). 10 chalcone compounds show greater than 6 activities against tubulin protein and they contain important structural features. The pharmacophoric features selected for creating sites were H-bond acceptor (A), hydrophobic group (H) and aromatic ring (R). Five featured common pharmacophore hypothesis was generated using different combinations of variants. Default values were selected for scoring function. Five pharmacophore hypothesis were generated, the best hypothesis AHHRR.10 having survival score of 4.824 were shown in Figure 1 the features represented in this hypothesis were one H-bond acceptor, two Hydrophobic and two Aromatic rings. The compound 13 show best fitness score of 3, the highest activity compound 3 show fitness score of 2.91 as shown in Figure 2a and 2b. The alignment of all active compounds and active/inactive compounds with their pharmacophoric features are shown in Figure 3a and 3b. The score of the hypothesis, distance and angle between different sites of AHHRR.10 hypothesis were presented in Table 3 , 4 and 5 respectively.
The best AHHRR.10 hypothesis were selected for atom based QSAR. The 3D QSAR model were generated in PHASE using 31 compounds as training and model was validated using 7 compounds as test set compounds with PLS factor. A four PLS factor model with good statistics and predicated ability was generated for the dataset. The statistical values were listed in Table 6 .
The QSAR result shows the best regression coefficient of R 2 (0.954), large value of F (136.9) and P value (4.563E-17), small value of standard deviation (0.135), RMSE (0.452) and high Pearson-P (0.886) values indicates statistically significant The QSAR model shows 95% variance explained by the observed and PHASE predicted activity graph shown in Figure 4 , which shows the fitting points were near to the regression line. The observed and predicted activities are summarized in Table 7 .
The 3D QSAR analysis of chalcone derivatives shows the following result, which contribute positively or negatively to activity. The QSAR model in PHASE represents as atom cubes, the blue color cube is positive coefficient and red color cube is negative coefficient. The positive coefficients indicate an increase in activity and negative coefficients indicate decrease in activity. The coefficients give a clue to find favorable and unfavorable functional groups.
Active compound 3 taken as reference compound and the blue and red color cubes are represented. Figure 5a demonstrates the red color cubes at H3 demonstrate negative potential of H-bond donors at the position of the compound. Figure 5b and 5c and demonstrates the blue color cubes on phenyl ring attached to chalcone moiety shows positive contribution of positive and negative ionic groups enhancing the activity. Figure 5d . illustrates electron withdrawing groups at A1, H3 and nitro group attached to phenyl shows positive potential of electron withdrawing groups. Figure 5e demonstrates positive contribution at H3 and H4 shows hydrophobic groups are favorable at this region and negative contribution on chalcone moiety and phenyl group shows the hydrophobic groups are unfavorable at this regions. Figure 5f demonstrates combined effect of QSAR model. The QSAR model explains the attachment of electron withdrawing groups to chalcone moiety; hydrophobic groups at H3 and H4; negative and positive ionic groups attached to the chalcone moiety enhances the activity of the chalcone derivatives towards tubulin receptor. Figure  6 clearly explains the favorable and unfavorable regions. Attachment of electron withdrawing groups, hydrophobic, positive and negative groups to chalcone moiety enhances the activity.
The reference ligand MDL-27048 has the docking score of 42.8 kcal/mol has the H-bond interactions with Gly144, Thr145. Compound 12 ((E)-3-(3-bromo-2-(2,6-dinitro-3-(trifluoromethyl) phenoxy)phenyl)-1-(4-chlorophenyl)prop-2-en-1-one) show highest docking score of 53.8 kcal/mol with H-bond interactions at Gln11, Thr145 amino Based on the results the molecules modified to improve the inhibitory activity toward tubulin.
Compound 3 were chosen as reference structure to design new set of compounds. The newly designed compounds and their predicted pIC 50 along with their structure were shown in Table 9 . The result Table 10 , the compounds showed better docking score than reference compound, which indicates that the model has good predictability and can be used to design novel compounds with better inhibitory activity.
CONCLUSION
Ligand based pharmacophore model generated for the series of chalcone derivatives with tubulin inhibitory action to understand the various structural features. PHASE was used to generate the pharmacophore model after successful pharmacophore generation the highest survival score model was used for further QSAR studies. The pharmacophore model reveals that one H-bond acceptor, two hydrophobic groups and two aromatic rings are essential features for ligand binding. QSAR model shows good statistical significance and explains presence of the electron withdrawing, negative and positive ionic groups on chalcone moiety enhances the activity of the compounds towards the tubulin protein. The QSAR model also supported by molecular docking studies the compounds having electron withdrawing group shows good interaction with the beta-tubulin receptor. The Docking study shows Gln11, Asn101, Thr145 are important amino acids in the active site to interact with the ligands. The designed molecules based on the model showed better activity and docking score for the compound 2 (E)-3-(2-bromo-5-methylphenyl)-1-(4-nitrophenyl) prop-2-en-1-one) and 6 ((E)-4-methyl-2-(3-(4-nitrophenyl)-3-oxoprop-1-en-1-yl)benzaldehyde), which indicates the model has good predictability and fruitful experimental work in progress.
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